Skip to content

AYURVEDIC MANAGEMENT OF ARTAVAKSHAYA AMONG ADOLESCENT GIRLS

MANAGEMENT OF ARTAVAKSHAYA AMONG ADOLESCENT GIRLS WITH LIFESTYLE MODIFICATION INCLUDING RAJASWALA PARICHARYA ALONG WITH RASAPACHAKA SYRUP AND SAPTAMRITA MISHRANA - AN OPEN LABELLED RANDOMIZED PLACEBO CONTROLLED CLINICAL TRIAL - NILL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/04/032862
Enrollment
60
Registered
2021-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N939- Abnormal uterine and vaginal bleeding, unspecified

Interventions

Intervention1: Group A Lifestyle modification including Rajaswala Paricharya along with Rasapachaka Syrup and Saptamrita Mishrana: Intervention agent Group A Rasapachaka Syrup and Saptamrita Mishrana

Sponsors

Institute of Teaching Research in Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adolescent girl who attained menarche Adolescent girl aged 12 years to 19 years having any of the Artavakshaya Lakshana like Yathochita Kala Adarshanam (Irregular Menstruation), Alpata (scanty menses) and Yonivedana (painful menses) Quantity of menstruation less than normal (which will be decided on basis of number of pad used per day) The duration of menstrual flow is 2 days or less If interval between two cycle exceeds more than 35 days Hb% >=7gm% Parents or caretaker willing to participate their girls in the clinical trial Note: Adolescent girl with the evidence of helminthiasis, GI tract diseases will be included after clearing the same

Exclusion criteria

Exclusion criteria: Adolescent girl who do not attain menarche Adolescent girl aged 19 years Adolescent girl having Overweight: >+1SD (BMI > 25-30 kg/m2 and Obesity: >+2SD (BMI >30 kg/m2) Hb% Adolescent girl having systemic disorders like Tuberculosis, DM type 1, Hypothyroidism, psychological illness, etc.

Design outcomes

Primary

MeasureTime frame
It is expected that the trial drug along with Lifestyle modification including Rajaswala Paricharya will break the pathogenesis of Artavakshaya among adolescent girlsTimepoint: 12 weeks

Secondary

MeasureTime frame
Improvement of general health of Adolescent girlsTimepoint: 12 weeks

Countries

India

Contacts

Public ContactJalpa Dineshbhai Patel

Institute of Teaching and Research in Ayurveda

drshilpadonga@yahoo.com9825646796

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026